share_log

润都股份(002923.SZ):硫酸羟氯喹获得化学原料药上市申请批准通知书

Zhuhai Rundu Pharmaceutical (002923.SZ): Hydroxychloroquine Sulfate has obtained the approval notice for the application for listing of chemical raw materials.

Zhitong Finance ·  Nov 3 03:22

Zhuhai Rundu Pharmaceutical (002923.SZ) announced that the company recently received the National Medical Products Administration's approval and issuance of hydroxy. . . .

Wisdom Financial APP news, Zhuhai Rundu Pharmaceutical (002923.SZ) announced that the company recently received the National Medical Products Administration's approval and issuance of the Hydroxychlorine Sulfate 'Notice of Approval for Market Application of Chemical Raw Materials'. This product is suitable for rheumatoid arthritis, juvenile chronic arthritis, discoid and systemic lupus erythematosus, and skin diseases induced or exacerbated by sunlight.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment